Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods. - Wikidata - awgldk - TriplyDB

Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.

Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.

http://www.wikidata.org/entity/Q37354917

about

Commentary: A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated with Initiation of Atypical Antipsychotic Therapy in Children and Adolescents Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management.Behavioral Weight Loss Treatment in Antipsychotic Treated Youth.Development of novel therapy of schizophrenia in children and adolescents.

P2860

Q33575907-260DEA4D-9498-4FD9-8185-688D58E82B7B Q34292768-E8BA24CE-669F-488A-9902-F2A509A6158C Q37028584-B562CD95-4668-4D37-9A9B-485F7E4ADABD Q38223714-B55A5A28-0379-452C-9257-9F40585E5AD2

P2860

Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.

http://www.wikidata.org/entity/Q37354917

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improving metabolic parameters ...... ationale, design, and methods.

@en

Improving metabolic parameters ...... ationale, design, and methods.

@nl

type

label

Improving metabolic parameters ...... ationale, design, and methods.

@en

Improving metabolic parameters ...... ationale, design, and methods.

@nl

prefLabel

Improving metabolic parameters ...... ationale, design, and methods.

@en

Improving metabolic parameters ...... ationale, design, and methods.

@nl

P1433

Q37354917-FFE8367A-B48B-455D-91F9-A110F5030EFD

P1476

Q37354917-EC1FEECC-A28A-4494-BF11-39FF295C51DE

P2093

Q37354917-05BC3478-0D9A-4320-B8D6-85E74FA8BC1D

Q37354917-129E4ECB-BE38-48FD-BF3F-31AD9C28E45D

Q37354917-22148943-13D5-49EE-930E-6A3A63D8E52F

Q37354917-27684811-EDAA-47E1-B65D-96A28FA0F163

Q37354917-32D5CF02-5AE1-447A-B2EB-E8B40E4EDA71

Q37354917-36C23FD6-A61D-45F3-8B74-EDAB38C5B9C5

Q37354917-38C6AD79-9485-47C3-A76C-50747E66E451

Q37354917-42211F67-E0B8-44AF-961A-D6938EAC2BAE

Q37354917-4C95A122-6EAD-48FC-A9EE-40968D9DCD15

Q37354917-58B5CA7C-8FE8-436D-84C2-2C2940F58E2A

P2860

Q37354917-0AD16DD2-C6BD-46D3-AC5C-E956A508E867

Q37354917-0DA0BB28-EA07-4051-AD24-9E6E61371866

Q37354917-17D17FCA-681C-4F27-BF08-B09C8B6644AA

Q37354917-1AB3BB45-BD24-4358-AC7E-87685C43387D

Q37354917-225DAE92-5E0D-425D-8C1F-78E66427BDB3

Q37354917-24C57FDF-DEE7-4F1B-B29B-BE483239DAE1

Q37354917-2CCC5BBF-2B22-469D-A10E-768CB56D376C

Q37354917-2EEEA59E-CD20-4BE9-9F0D-7F9D3F016327

Q37354917-30EFDDF2-4469-4D87-8E31-90CF34815190

Q37354917-33501912-9DBB-49B7-A8FB-8080E4563908

P2888

Q37354917-8B23AD9D-625D-4013-9270-3EBC718B28B6

P304

Q37354917-84692945-7115-40F1-B041-8CB53E361CCE

P31

Q37354917-F2F7FA29-06E7-45AA-9252-75A097D307B1

P356

Q37354917-2ECDACDD-1696-4BD9-8051-4730E211BA12

P433

Q37354917-5743B044-5A20-40CC-827C-AA00DFEAFA36

P478

Q37354917-635FB178-3D62-4A23-8AA6-5C738091AFAF

P577

Q37354917-A88C629B-37ED-4492-A615-F71AE3A51C94

P5875

Q37354917-16099BBF-CD69-4377-9950-25D1A33987CE

P6179

Q37354917-F74DF6E6-889F-4869-8BBA-27414D008FAB

P698

Q37354917-ECEF4448-284F-46C1-885A-9E22A144C5E0

P932

Q37354917-1D95DDBE-A48A-468C-A721-0DE33A5D52D5

P356

P1433

Child and Adolescent Psychiatry and Mental Health

P1476

Improving metabolic parameters ...... ationale, design, and methods.

@en

P2093

Abigail Scheer

http://www.w3.org/2001/XMLSchema#string

Cheryl Alderman

http://www.w3.org/2001/XMLSchema#string

Christoph U Correll

http://www.w3.org/2001/XMLSchema#string

Courtney Keeton

http://www.w3.org/2001/XMLSchema#string

Erin Santana

http://www.w3.org/2001/XMLSchema#string

Eva Sheridan

http://www.w3.org/2001/XMLSchema#string

Gloria M Reeves

http://www.w3.org/2001/XMLSchema#string

Irmgard Borner

http://www.w3.org/2001/XMLSchema#string

Jacqueline L Johnson

http://www.w3.org/2001/XMLSchema#string

Kristin Bussell

http://www.w3.org/2001/XMLSchema#string

P2860

The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems

Management of antipsychotic-related weight gain

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935

Market withdrawal of new molecular entities approved in the United States from 1980 to 2009

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

Tracking of body mass index in children in relation to overweight in adulthood.

First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.

P2888

P304

31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1753-2000-7-31

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255956462

http://www.w3.org/2001/XMLSchema#string

P6179

1002161269

http://www.w3.org/2001/XMLSchema#string

P698

23947389

http://www.w3.org/2001/XMLSchema#string

P932

3846140

http://www.w3.org/2001/XMLSchema#string